Abstract

Hypertension remains the primary driver of Cardiovascular Diseases (CVDs) and mortality. Dyslipidaemia is a common risk factor for CVDs in hypertensive patients, and their coexistence significantly increases the risk of CVDs. Furthermore, epidemiologic studies indicate that there are U-shaped curves between cholesterol levels of HDL-C and CVDs-related mortality in patients with hypertension, in which CVDs are paradoxically increased in those with elevated HDLC levels. On the one hand, HDL-C levels and HDL particle function are associated with the pathogenesis and prognosis of hypertension. On the other hand, hypertension leads to lower HDL-C levels and worse HDL function through various changes in HDL granule proteome and liposome. In view of these findings, the relationship between hypertension and HDL-C necessitates a renewed analysis. This study summarizes the findings from clinical trials and basic research to determine the relationship between HDL-C and hypertension.

Full Text

Published Version

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.